SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-18-009568
Filing Date
2018-07-02
Accepted
2018-07-02 17:01:12
Documents
7
Period of Report
2018-07-02

Document Format Files

Seq Description Document Type Size
1 pre14a.htm PRE 14A 667198
2 image_001.jpg GRAPHIC 257002
3 img_001.jpg GRAPHIC 6229
4 img_002.jpg GRAPHIC 2460
5 img_003.jpg GRAPHIC 6238
6 img_004.jpg GRAPHIC 2610
7 img_005.jpg GRAPHIC 2580
  Complete submission text file 0001493152-18-009568.txt   1050584
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37648 | Film No.: 18933545
SIC: 2835 In Vitro & In Vivo Diagnostic Substances